DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 03 · Volume 44 · Mai 2011 DOI: 10.1055/s-002-22003

Original Paper

87
Holzer, L.; Preuss, U.; Baumgartner, L.; Jaugey, L.; Urben, S.; Halfon, O.; Baumann, P.: Quetiapine in Adolescents with Non-Affective Psychotic Disorders: An Open-Label Trial
102
Preuss, U. W.; Zimmermann, J.; Watzke, S.; Langosch, J.; Siafarikas, N.; Wong, J. W. M.; Hamm, A.; Weike, A.: Short-Term Prospective Comparison of Prepulse Inhibition between Schizophrenic Patients and Healthy Controls
114
Xiang, Y.-T.; Wang, C.-Y.; Si, T.-M.; Lee, E. H. M.; He, Y.-L.; Ungvari, G. S.; Chiu, H. F. K.; Yang, S.-Y.; Chong, M.-Y.; Tan, C.-H.; Kua, E.-H.; Fujii, S.; Sim, K.; Yong, K. H.; Trivedi, J. K.; Chung, E.-K.; Udomratn, P.; Chee, K.-Y.; Sartorius, N.; Shinfuku, N.: Use of Anticholinergic Drugs in Patients with Schizophrenia in Asia from 2001 to 2009

Letter

119
Mutschler, J.; Grosshans, M.; Herwig, U.; Heekeren, K.; Kawohl, W.; Brühl, A.: Pregabalin-Induced Suicidal Ideations
120
Specka, M.; Lieb, B.; Kuhlmann, T.; Frommann, N.; Wobrock, T.; Schifano, F.; Gaebel, W.; Scherbaum, N.: Marked Reduction of Heavy Drinking did not Reduce Nicotine Use over 1 Year in a Clinical Sample of Alcohol-Dependent Patients